Increased aggression in males in transgenic Tg2576 mouse model of Alzheimer's disease

Behavioural Brain Research

Volumn 216, Issue 1, 2011, Pages 77-83

  Alexander, Gaukhman ^a   Hanna, Amanda ^a   Serna, Vanida ^a   Younkin, Linda ^a   Younkin, Steve ^a   Janus, Christopher ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Aggressive behaviour; Alzheimer's disease; Amyloid; Resident intruder test; Tg2576 mouse model

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

AGGRESSION; AGITATION; ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; GENE EXPRESSION; GENOTYPE; GROOMING; LATENT PERIOD; MALE; MOUSE; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TRANSGENIC MOUSE;

AGGRESSION; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, TRANSGENIC;

EID: 78149469993     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.07.016     Document Type: Article

References (60)

1. Reisberg B., Borenstein J., Salob S.P., Ferris S.H., Franssen E., Georgotas A. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987, 48(Suppl.):9-15.
2. Aalten P., de Vugt M.E., Lousberg R., Korten E, Jaspers N., Senden B., et al. Behavioral problems in dementia: a factor analysis of the neuropsychiatric inventory. Dement Geriatr Cogn Disord 2003, 15:99-105.
3. Burns A., Jacoby R., Levy R. Psychiatric phenomena in Alzheimer's disease. IV: disorders of behaviour. Br J Psychiatry 1990, 157:86-94.
4. Senanarong V., Cummings J.L., Fairbanks L., Mega M., Masterman D.M., O'Connor S.M., et al. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction. Dement Geriatr Cogn Disord 2004, 17:14-20.
5. Murman D.L., Chen Q., Colucci P.M., Colenda C.C., Gelb D.J., Liang J. Comparison of healthcare utilization and direct costs in three degenerative dementias. Am J Geriatr Psychiatry 2002, 10:328-336.
6. Murman D.L., Chen Q., Powell M.C., Kuo S.B., Bradley C.J., Colenda C.C. The incremental direct costs associated with behavioral symptoms in AD. Neurology 2002, 59:1721-1729.
7. Beeri M.S., Werner P., Davidson M., Noy S. The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients. Int J Geriatr Psychiatry 2002, 17:403-408.
8. Ballard C.G., Gauthier S., Cummings J.L., Brodaty H., Grossberg G.T., Robert P., et al. Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol 2009, 5:245-255.
9. Matthews K.L., Chen C.P., Esiri M.M., Keene J., Minger S.L., Francis P.T. Noradrenergic changes, aggressive behavior, and cognition in patients with dementia. Biol Psychiatry 2002, 51:407-416.
10. Ashe K.H. Mechanisms of memory loss in Abeta and tau mouse models. Biochem Soc Trans 2005, 33:591-594.
11. Dodart J.C., Mathis C., Bales K.R., Paul S.M. Does my mouse have Alzheimer's disease?. Genes Brain Behav 2002, 1:142-155.
12. Eriksen J.L., Janus C.G. Plaques, tangles and memory loss in mouse models of neurodegeneration. Behav Genet 2007, 37:79-100.
13. Price D.L., Sisodia S.S. Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci 1998, 21:479-505.
14. Seabrook G.R., Rosahl T.W. Transgenic animals relevant to Alzheimer's disease. Neuropharmacology 1999, 38:1-17.
15. Asuni A.A., Boutajangout A., Quartermain D., Sigurdsson E.M. Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements. J Neurosci 2007, 27:9115-9129.
16. Bacskai B.J., Kajdasz S.T., McLellan M.E., Games D., Seubert P., Schenk D., et al. Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy. J Neurosci 2002, 22:7873-7878.
17. Dodart J.C., Bales K.R., Gannon K.S., Greene S.J., DeMattos R.B., Mathis C., et al. Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat Neurosci 2002, 5:452-457.
18. Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D., et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 2000, 408:979-982.
19. Maier M., Seabrook T.J., Lazo N.D., Jiang L., Das P., Janus C., et al. Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response. J Neurosci 2006, 26:4717-4728.
20. Sigurdsson E.M., Knudsen E., Asuni A., Fitzer-Attas C., Sage D., Quartermain D., et al. An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives. J Neurosci 2004, 24:6277-6282.
21. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., et al. Correlative memory deficits, a-beta elevation, and amyloid plaques in transgenic mice. Science 1996, 274:99-102.
22. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 2001, 21:372-381.
23. Irizarry M.C., McNamara M., Fedorchak K., Hsiao K., Hyman B.T. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 1997, 56:965-973.
24. Frautschy S.A., Yang F., Irrizarry M., Hyman B., Saido T.C., Hsiao K., et al. Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol 1998, 152:307-317.
25. Lim G.P., Yang F., Chu T., Chen P., Beech W., Teter B., et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 2000, 20:5709-5714.
26. Tan J., Town T., Paris D., Mori T., Suo Z., Crawford F., et al. Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science 1999, 286:2352-2355.
27. Pappolla M.A., Chyan Y.J., Omar R.A., Hsiao K., Perry G., Smith M.A., et al. Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am J Pathol 1998, 152:871-877.
28. Smith M.A., Hirai K., Hsiao K., Pappolla M.A., Harris P.L., Siedlak S.L., et al. Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 1998, 70:2212-2215.
29. Kumar-Singh S., Dewachter I., Moechars D., Lubke U., De Jonghe C., Ceuterick C., et al. Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. Neurobiol Dis 2000, 7:9-22.
30. Minkeviciene R., Banerjee P., Tanila H. Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease. J Pharmacol Exp Ther 2004, 311:677-682.
31. Moechars D., Dewachter I., Lorent K., Reverse D., Baekelandt V., Naidu A., et al. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 1999, 274:6483-6492.
32. Moechars D., Gilis M., Kuiperi C., Laenen I., Van Leuven F. Aggressive behaviour in transgenic mice expressing APP is alleviated by serotonergic drugs. Neuroreport 1998, 9:3561-3564.
33. Moechars D., Lorent K., De Strooper B., Dewachter I., Van Leuven F. Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J 1996, 15:1265-1274.
34. Pugh P.L., Richardson J.C., Bate S.T., Upton N., Sunter D. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease. Behav Brain Res 2007, 178:18-28.
35. Vloeberghs E., Van Dam D., Coen K., Staufenbiel M., De Deyn P.P. Aggressive male APP23 mice modeling behavioral alterations in dementia. Behav Neurosci 2006, 120:1380-1383.
36. Thurmond J.B. Technique for producing and measuring territorial aggression using laboratory mice. Physiol Behav 1975, 14:879-881.
37. Guillot P.V., Chapouthier G. Intermale aggression and dark/light preference in ten inbred mouse strains. Behav Brain Res 1996, 77:211-213.
38. Kessler S., Elliott G.R., Orenberg E.K., Barchas J.D. A genetic analysis of aggressive behavior in two strains of mice. Behav Genet 1977, 7:313-321.
39. Bartolomucci A., Palanza P., Gaspani L., Limiroli E., Panerai A.E., Ceresini G., et al. Social status in mice: behavioral, endocrine and immune changes are context dependent. Physiol Behav 2001, 73:401-410.
40. Bartolomucci A., Palanza P., Sacerdote P., Panerai A.E., Sgoifo A., Dantzer R., et al. Social factors and individual vulnerability to chronic stress exposure. Neurosci Biobehav Rev 2005, 29:67-81.
41. Crawley J.N. What's wrong with my mouse? Behavioural phenotyping of transgenic and knockout mice 2007, John Wiley & Sons Inc., New Jersey. 2nd ed.
42. Guillot P.V., Carlier M., Maxson S.C., Roubertoux P.L. Intermale aggression tested in two procedures, using four inbred strains of mice and their reciprocal congenics: Y chromosomal implications. Behav Genet 1995, 25:357-360.
43. Kopp C. Locomotor activity rhythm in inbred strains of mice: implications for behavioural studies. Behav Brain Res 2001, 125:93-96.
44. Hinde R.A. On the design of check-sheets. Primates 1973, 14.
45. Martin P., Bateson P. Measuring behaviour 1996, Cambridge University Press, Cambridge.
46. Howell D.C. Statistical methods for psychology 1992, Duxbury Press, Belmont, CA.
47. Stevens J. Intermediate statistics: a modern approach 1990, Lawrence Erlbaum Associates, Inc., Hillsdale, NJ.
48. Siegel S., Castellan J.N.J. Nonparametric statistics for behavioral sciences 1988, McGraw-Hill Book Company, New York.
49. Dewachter I., vanDorpe J., Spittaels K., Tesseur I., Van_Den_Haute C., Moechars D., et al. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice. Exp Gerontol 2000, 35:831-841.
50. Spires T.L., Hyman B.T. Transgenic models of Alzheimer's disease: learning from animals. NeuroRx 2005, 2:423-437.
51. Guenette S.Y., Tanzi R.E. Progress toward valid transgenic mouse models for Alzheimer's disease. Neurobiol Aging 1999, 20:201-211.
52. Price D.L., Tanzi R.E., Borchelt D.R., Sisodia S.S. Alzheimer's disease: genetic studies and transgenic models. Annu Rev Genet 1998, 32:461-493.
53. Banbury Conference on Genetic Background in Mice Mutant mice and neuroscience: recommendations. Neuron 1997, 19:755-759.
54. Lehman E.J., Kulnane L.S., Gao Y., Petriello M.C., Pimpis K.M., Younkin L., et al. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse. Hum Mol Genet 2003, 12:2949-2956.
55. Miczek K.A., Maxson S.C., Fish E.W., Faccidomo S. Aggressive behavioral phenotypes in mice. Behav Brain Res 2001, 125:167-181.
56. Bartolomucci A., Pederzani T., Sacerdote P., Panerai A.E., Parmigiani S., Palanza P. Behavioral and physiological characterization of male mice under chronic psychosocial stress. Psychoneuroendocrinology 2004, 29:899-910.
57. Jost B.C., Grossberg G.T. The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study. J Am Geriatr Soc 1996, 44:1078-1081.
58. Cooper J.K., Mungas D., Weiler P.G. Relation of cognitive status and abnormal behaviors in Alzheimer's disease. J Am Geriatr Soc 1990, 38:867-870.
59. Crowcroft P., Rowe F.P. Social organization and territorial behaviour in the wild house mouse. Proc Zool Soc Lond 1963, 140:517-531.
60. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 2006, 440:352-357.